Variant Gene Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs2369049
rs2369049
0.010 GeneticVariation BEFREE We used polymerase chain reaction to genotype the rs4680 (Val158Met) and rs4633 (His62His) variants in the catechol-O-methyltransferase gene and rs2369049 (A > G) and rs7158782 (A > G) variants in the T-cell leukemia/lymphoma 1 A gene. 29912452

2019

dbSNP: rs4633
rs4633
0.010 GeneticVariation BEFREE We used polymerase chain reaction to genotype the rs4680 (Val158Met) and rs4633 (His62His) variants in the catechol-O-methyltransferase gene and rs2369049 (A > G) and rs7158782 (A > G) variants in the T-cell leukemia/lymphoma 1 A gene. 29912452

2019

dbSNP: rs4680
rs4680
0.010 GeneticVariation BEFREE We used polymerase chain reaction to genotype the rs4680 (Val158Met) and rs4633 (His62His) variants in the catechol-O-methyltransferase gene and rs2369049 (A > G) and rs7158782 (A > G) variants in the T-cell leukemia/lymphoma 1 A gene. 29912452

2019

dbSNP: rs7158782
rs7158782
0.010 GeneticVariation BEFREE We used polymerase chain reaction to genotype the rs4680 (Val158Met) and rs4633 (His62His) variants in the catechol-O-methyltransferase gene and rs2369049 (A > G) and rs7158782 (A > G) variants in the T-cell leukemia/lymphoma 1 A gene. 29912452

2019

dbSNP: rs1800682
rs1800682
0.010 GeneticVariation BEFREE We have previously shown that an IFN-responsive <i>FAS</i> promoter polymorphism in a STAT1 binding site (rs1800682) is associated to ATL susceptibility and survival. 29721391

2018

dbSNP: rs759834538
rs759834538
0.010 GeneticVariation BEFREE Transforming activity was further demonstrated by the ability of the FBXW7 D510E mutant to provide IL-2-independent growth of Tax-immortalized human T cells and increase the tumor formation in a xenograft mouse model of ATL. 27247421

2016

dbSNP: rs121913529
rs121913529
0.010 GeneticVariation BEFREE To study the impact of oncogenic K-Ras on T-cell leukemia/lymphoma development and progression, we made use of a conditional K-Ras(G12D) murine knockin model, in which oncogenic K-Ras is expressed from its endogenous promoter. 18663146

2008

dbSNP: rs1322648460
rs1322648460
0.010 GeneticVariation BEFREE To study the impact of oncogenic K-Ras on T-cell leukemia/lymphoma development and progression, we made use of a conditional K-Ras(G12D) murine knockin model, in which oncogenic K-Ras is expressed from its endogenous promoter. 18663146

2008

dbSNP: rs752021744
rs752021744
0.010 GeneticVariation BEFREE To study the impact of oncogenic K-Ras on T-cell leukemia/lymphoma development and progression, we made use of a conditional K-Ras(G12D) murine knockin model, in which oncogenic K-Ras is expressed from its endogenous promoter. 18663146

2008

dbSNP: rs28934576
rs28934576
0.010 GeneticVariation BEFREE One patient had no p53 mutation in his leukemic cells during chronic phase of ATL, but had a homozygous point mutation at codon 273 (Arg to His) when he progressed to acute ATL. 1730092

1992